China, Canada and US labs collaborate over neurological disorder therapies

10-04-2019

China, Canada and US labs collaborate over neurological disorder therapies

LightSpring / Shutterstock.com

Chinese companies have entered into a research agreement with scientists in the US and Canada to develop a therapy for neurological disorders by using the natural power of the immune system.


I-MAB, Jiangsu Nhwa Pharmaceutical, Brigham and Women’s Hospital, Biodextris, neurological disorders, collaboration

LSIPR